Literature DB >> 2153461

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.

G Uzé1, G Lutfalla, I Gresser.   

Abstract

A cDNA coding for the human interferon alpha receptor has been cloned using a gene transfer approach. This consists of transferring human DNA to mouse cells and selecting for cells sensitive to human interferon alpha. The transfected cells expressed the human interferon alpha receptor, and a 5 kb human DNA was isolated from a secondary transfectant. This DNA defects an mRNA present in human cells and was used to clone a 2.7 kb cDNA from a library constructed from human Daudi cells. The sequence of the cDNA is presented. It codes for a glycoprotein of 557 amino acids with an N-terminal hydrophobic region and a single transmembrane-spanning segment. Mouse cells expressing the cDNA become sensitive to the antiviral activity of and express binding sites for human interferon alpha, demonstrating that the cloned cDNA encodes a functional human interferon alpha receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153461     DOI: 10.1016/0092-8674(90)90738-z

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  101 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; C Lee; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking.

Authors:  L C Roisman; J Piehler; J Y Trosset; H A Scheraga; G Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

4.  IFNalpha/beta promotes cell survival by activating NF-kappa B.

Authors:  C H Yang; A Murti; S R Pfeffer; L Basu; J G Kim; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.

Authors:  Yuhki Yamaguchi; Keisuke Hino; Daisuke Fujiwara; Fenyu Ren; Yoshiharu Katoh; Yasuhiro Satoh; Kiwamu Okita
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

6.  Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha.

Authors:  Raj Deonarain; Amit Verma; Andrew C G Porter; Dirk R Gewert; Leonidas C Platanias; Eleanor N Fish
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

7.  Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.

Authors:  C A Lingwood; S K Yiu
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 8.  Mouse chromosome 16.

Authors:  R H Reeves; R D Miller
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

9.  Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Authors:  S N Constantinescu; E Croze; A Murti; C Wang; L Basu; D Hollander; D Russell-Harde; M Betts; V Garcia-Martinez; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.

Authors:  L Lanza; L Peirano; O Bosco; P Contini; G Filaci; M Setti; F Puppo; F Indiveri; M Scudeletti
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.